ARX:ASX
Aroa Biosurgery Ltd
A$0.70
arrow_upward
+2.21%(+0.015) 1D
May 29, 4:10:03 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.67
High
A$0.70
Low
A$0.66
Mkt. cap
240.40M
Avg. vol.
251.16K
Volume
400.65K
P/E ratio
66.32
52-wk high
A$0.80
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.67
High
A$0.70
Low
A$0.66
Mkt. cap
240.40M
Avg. vol.
251.16K
Volume
400.65K
P/E ratio
66.32
52-wk high
A$0.80
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From sources across the web
Yahoo Finance
·
2 hours ago
This Unstoppable Vanguard ETF Has More Than Doubled the S&P 500 in the Last 10 Years. Could It Make You a Millionaire?
Simply Wall Street
·
1 hour ago
Trip.com Group (NasdaqGS:TCOM) Valuation Check After New AI Tools Partnerships And Global Travel Grants
TechStock²
·
1 hour ago
ISRG slips even as Nasdaq hits highs; traders look ahead
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd
AI content may include mistakes. Learn more